Trials / Withdrawn
WithdrawnNCT04525170
Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A
Clinical Evaluation of Hydra-PEG (Polyethylene Glycol) Treatment (HPT) Treated Rigid Contact Lenses Made From Hexafocon A
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Contamac Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This will be an up to six months, subject-masked, contralateral, parallel-group, randomised, daily wear study. All subjects will wear the Test lens in one eye and the Control lens in the other eye. Data from the first four weeks of Test and Control lens exposure will be used for the FDA 510 (k) submission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HPT treatment | |
| DEVICE | untreated |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2020-08-25
- Last updated
- 2020-08-25
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04525170. Inclusion in this directory is not an endorsement.